Candidate anti-tuberculosis medicines and regimens under clinical evaluation.

Michael HoelscherDavid Barros-AguirreMasoud DaraNorbert HeinrichEugene SunChristoph LangeSimon TiberiCharles Wells

Published in: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases (2024)

A large number of potential anti-TB candidate medicines and innovations in clinical trial design for the evaluation of regimens, rather than single medicines, provide hope for improvements in the treatment of TB.

Keyphrases

clinical evaluation
mycobacterium tuberculosis
clinical trial
pulmonary tuberculosis
open label
study protocol
hiv aids
emergency department
phase ii
risk assessment
climate change
human immunodeficiency virus